ad image

BlueSphere Bio

1 / 1
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
Cell Therapy

Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner

Mark Shlomchik, M.D., Ph.D.

BlueSphere Bio

PAO-06-022-CL-03Jun 06, 2022
Q: What’s the key to being a leader in the industry?
Leadership

Q: What’s the key to being a leader in the industry?

Pharma's Almanac

PAO-03-022-RT-02Mar 11, 2022
Q: What important company milestone do you anticipate reaching in 2022?
Milestones

Q: What important company milestone do you anticipate reaching in 2022?

Pharma's Almanac

PAO-03-022-RT-01Mar 11, 2022
1 / 1